Publication | Open Access

Clinical risk factors predicting genital fungal infections with sodium–glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit

Sodium–glucose Cotransporter 2Genital Fungal InfectionsFungal PathogenClinical EpidemiologyVaginitisClinical Risk FactorsInfection ControlPublic HealthClinical Infectious DiseaseMedicineAntimicrobial ResistanceEpidemiology